I am sitting down with an advisor and a client this afternoon to discuss a portfolio. Usual enough. But in this case, the portfolio looks a bit different. It has a large number of individual stocks, most of which are in the tech space. Of course, it has done very well over the past year or more.

One of the most common types of questions I have gotten recently has been around interest rates. Rates are going up, and the concern has largely been whether this is a sign of pending inflation. As both my colleague Anu Gaggar and I have written recently, the answer is no, higher rates do not mean inflation is coming. They do mean several other things, however—some bad and some good.

Today I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, we appear to be well past the peak of the third wave, with daily infection rates and hospitalizations down. A more contagious variant of the virus could start another wave of infections, although there are no signs of that happening yet.

*Starting next week, February 25, I’ll be publishing my coronavirus update every other week.

My colleague Sam Millette, senior investment research analyst on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Market Risk Update. Thanks for the assist, Sam!

Markets took a breather in January, as month-end volatility led to a mixed month for major equity indices to start the year. This volatility caused the S&P 500 to decline by 1.01 percent during the month, while the Dow Jones Industrial Average dropped 1.95 percent. The Nasdaq Composite managed to record a 1.44 percent gain. While we have seen markets largely recover to start February, the month-end volatility is a good reminder of the risks markets continue to face.

For the third week in a row, the big picture continues to be very positive. On the medical front, all three major data series—new cases, positive testing rates, and hospitalizations—have continued to trend down, while vaccinations continue to scale up. If current trends continue, we are through the worst of the pandemic and should see continued improvement.

My colleague Sam Millette, senior investment research analyst on Commonwealth’s Investment Management and Research team, has helped me put together this month’s Economic Risk Factor Update. Thanks for the assist, Sam!

The economy showed moderate growth in January, despite the lingering headwind of the third wave of the pandemic. There were signs toward month-end that federal stimulus and an improving public health picture started to have a positive impact on the economic recovery, with a return to job growth and increases in business and consumer confidence. Reflecting the improvements, long-term interest rates also began to show signs of normalization.

January was a month of transition. Markets took a break, with small gains or declines. The presidential inauguration handed the reins from the Trump administration to the Biden administration. Winter finally arrived, at least here in Massachusetts. And with the start of mass vaccinations, we began the transition to get past the COVID-19 pandemic.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, new daily infection rates and hospitalizations were down, and we saw improvement in positive testing rates. Although the threat of a more contagious variant of the virus remains, substantial progress on vaccinations should help offset that risk.

For the second week in a row, the big picture continues to be very positive. On the medical front, all three major data series—new cases, positive testing rates, and hospitalizations—have continued to trend down, while vaccinations continue to scale up. If current trends continue, we are through the worst of the pandemic and should see continued improvement.